ZA200006303B - Process for the production or R-(+)-6-carboxamido-3-N-methylamino-1,2,3,4-tetrahydrocarbazole. - Google Patents
Process for the production or R-(+)-6-carboxamido-3-N-methylamino-1,2,3,4-tetrahydrocarbazole. Download PDFInfo
- Publication number
- ZA200006303B ZA200006303B ZA200006303A ZA200006303A ZA200006303B ZA 200006303 B ZA200006303 B ZA 200006303B ZA 200006303 A ZA200006303 A ZA 200006303A ZA 200006303 A ZA200006303 A ZA 200006303A ZA 200006303 B ZA200006303 B ZA 200006303B
- Authority
- ZA
- South Africa
- Prior art keywords
- methylamino
- tetrahydrocarbazole
- salt
- mixture
- cyano
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 33
- 238000004519 manufacturing process Methods 0.000 title description 4
- 150000003839 salts Chemical class 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 25
- 150000001875 compounds Chemical class 0.000 claims description 20
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims description 19
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 18
- 238000002360 preparation method Methods 0.000 claims description 14
- 239000012453 solvate Substances 0.000 claims description 12
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 claims description 11
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- KJIMZXWXSLVBEO-UHFFFAOYSA-N 4-(methylamino)cyclohexan-1-one Chemical compound CNC1CCC(=O)CC1 KJIMZXWXSLVBEO-UHFFFAOYSA-N 0.000 claims description 6
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 6
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims description 6
- 230000007062 hydrolysis Effects 0.000 claims description 5
- 238000006460 hydrolysis reaction Methods 0.000 claims description 5
- COKVDTKAWIFNTH-UHFFFAOYSA-N 3,3-dimethyl-1,5-dioxaspiro[5.5]undecan-9-one Chemical compound O1CC(C)(C)COC11CCC(=O)CC1 COKVDTKAWIFNTH-UHFFFAOYSA-N 0.000 claims 1
- DZUUSHCOMPROCJ-UHFFFAOYSA-N 4-hydrazinylbenzonitrile Chemical compound NNC1=CC=C(C#N)C=C1 DZUUSHCOMPROCJ-UHFFFAOYSA-N 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 42
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 27
- 238000006243 chemical reaction Methods 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- 239000007787 solid Substances 0.000 description 15
- CBTITARLOCZPDU-UHFFFAOYSA-N 1h-indole-2-carbonitrile Chemical compound C1=CC=C2NC(C#N)=CC2=C1 CBTITARLOCZPDU-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- 239000012458 free base Substances 0.000 description 5
- -1 indole nitrile compound Chemical class 0.000 description 5
- ODHCTXKNWHHXJC-GSVOUGTGSA-N 5-oxo-D-proline Chemical compound OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 235000011167 hydrochloric acid Nutrition 0.000 description 4
- 229940043131 pyroglutamate Drugs 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- ZNWLFTSPNBLXGL-UHFFFAOYSA-N 4-(1,4-dioxaspiro[4.5]decan-8-yl)cyclohexan-1-one Chemical compound C1CC(=O)CCC1C1CCC2(OCCO2)CC1 ZNWLFTSPNBLXGL-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 239000011369 resultant mixture Substances 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical class OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- XKLNOVWDVMWTOB-UHFFFAOYSA-N 2,3,4,9-tetrahydro-1h-carbazole Chemical compound N1C2=CC=CC=C2C2=C1CCCC2 XKLNOVWDVMWTOB-UHFFFAOYSA-N 0.000 description 2
- UXDLLFIRCVPPQP-UHFFFAOYSA-N 4-hydrazinylbenzonitrile;hydrochloride Chemical compound [Cl-].[NH3+]NC1=CC=C(C#N)C=C1 UXDLLFIRCVPPQP-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- BIVUUOPIAYRCAP-UHFFFAOYSA-N aminoazanium;chloride Chemical compound Cl.NN BIVUUOPIAYRCAP-UHFFFAOYSA-N 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- DCZFGQYXRKMVFG-UHFFFAOYSA-N cyclohexane-1,4-dione Chemical compound O=C1CCC(=O)CC1 DCZFGQYXRKMVFG-UHFFFAOYSA-N 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 239000012258 stirred mixture Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- WPDCBQPOJXEMKM-UHFFFAOYSA-N 6-(methylamino)-6,7,8,9-tetrahydro-5h-carbazole-3-carbonitrile Chemical compound N1C2=CC=C(C#N)C=C2C2=C1CCC(NC)C2 WPDCBQPOJXEMKM-UHFFFAOYSA-N 0.000 description 1
- OWIOWWPDSOTTNG-UHFFFAOYSA-N 6-amino-6,7,8,9-tetrahydro-5h-carbazole-3-carboxamide;hydrochloride Chemical compound Cl.N1C2=CC=C(C(N)=O)C=C2C2=C1CCC(N)C2 OWIOWWPDSOTTNG-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- XCINZDTUNROCPR-UHFFFAOYSA-N C12=CC=CC=C2N(NC)C2=C1CCCC2 Chemical compound C12=CC=CC=C2N(NC)C2=C1CCCC2 XCINZDTUNROCPR-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- HCUARRIEZVDMPT-UHFFFAOYSA-N Indole-2-carboxylic acid Chemical compound C1=CC=C2NC(C(=O)O)=CC2=C1 HCUARRIEZVDMPT-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- LVZGQWKTUCVPBQ-UHFFFAOYSA-N acetic acid;trifluoroborane Chemical compound CC(O)=O.FB(F)F LVZGQWKTUCVPBQ-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000000609 carbazolyl group Chemical class C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000004296 chiral HPLC Methods 0.000 description 1
- 238000010961 commercial manufacture process Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- UZUODNWWWUQRIR-UHFFFAOYSA-L disodium;3-aminonaphthalene-1,5-disulfonate Chemical compound [Na+].[Na+].C1=CC=C(S([O-])(=O)=O)C2=CC(N)=CC(S([O-])(=O)=O)=C21 UZUODNWWWUQRIR-UHFFFAOYSA-L 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- AGIWCGXGVSTDQF-UHFFFAOYSA-N n,3,3-trimethyl-1,5-dioxaspiro[5.5]undecan-9-amine Chemical compound C1CC(NC)CCC21OCC(C)(C)CO2 AGIWCGXGVSTDQF-UHFFFAOYSA-N 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808069.0A GB9808069D0 (en) | 1998-04-16 | 1998-04-16 | Novel processes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200006303B true ZA200006303B (en) | 2001-05-30 |
Family
ID=10830430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200006303A ZA200006303B (en) | 1998-04-16 | 2000-11-03 | Process for the production or R-(+)-6-carboxamido-3-N-methylamino-1,2,3,4-tetrahydrocarbazole. |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6359146B1 (pl) |
| EP (1) | EP1070051B1 (pl) |
| JP (1) | JP4756740B2 (pl) |
| KR (1) | KR100612183B1 (pl) |
| CN (1) | CN1200931C (pl) |
| AR (1) | AR015771A1 (pl) |
| AU (1) | AU3437099A (pl) |
| BR (1) | BR9909627A (pl) |
| CA (1) | CA2328345C (pl) |
| CY (1) | CY1116418T1 (pl) |
| CZ (1) | CZ297303B6 (pl) |
| DK (1) | DK1070051T3 (pl) |
| EA (1) | EA004586B1 (pl) |
| EE (1) | EE05156B1 (pl) |
| ES (1) | ES2541432T3 (pl) |
| GB (1) | GB9808069D0 (pl) |
| HK (1) | HK1037615A1 (pl) |
| HR (1) | HRP20000683B1 (pl) |
| HU (1) | HU230559B1 (pl) |
| ID (1) | ID26783A (pl) |
| IL (1) | IL139017A (pl) |
| MX (1) | MXPA00010127A (pl) |
| MY (1) | MY126530A (pl) |
| NO (1) | NO317883B1 (pl) |
| PL (1) | PL210864B1 (pl) |
| PT (1) | PT1070051E (pl) |
| SI (1) | SI1070051T1 (pl) |
| SK (1) | SK286425B6 (pl) |
| TR (1) | TR200100142T2 (pl) |
| TW (1) | TWI255812B (pl) |
| UA (1) | UA70943C2 (pl) |
| WO (1) | WO1999054302A1 (pl) |
| YU (1) | YU62800A (pl) |
| ZA (1) | ZA200006303B (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010073253A1 (en) * | 2008-12-22 | 2010-07-01 | Natco Pharma Limited | Method for preparing an optically active frovatriptan |
| WO2011095803A1 (en) * | 2010-02-02 | 2011-08-11 | Generics [Uk] Limited | Hplc method for analyzing frovatriptan |
| EP2816030A1 (en) | 2013-06-20 | 2014-12-24 | Duke Chem, S. A. | Process for the preparation of frovatriptan and its enantiomer |
| CN103421855B (zh) * | 2013-08-13 | 2016-04-13 | 凯莱英医药集团（天津）股份有限公司 | 一种制备琥珀酸夫罗曲坦关键中间体的方法 |
| CN104529871A (zh) * | 2014-12-22 | 2015-04-22 | 青岛正大海尔制药有限公司 | 一种琥珀酸呋罗曲坦的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2528267A (en) * | 1950-10-31 | Eobeet j | ||
| NL7514300A (nl) * | 1975-12-09 | 1977-06-13 | Stamicarbon | Werkwijze voor de bereiding van optisch actief fenylglycineamide. |
| JPS6259274A (ja) * | 1985-05-29 | 1987-03-14 | Sumitomo Pharmaceut Co Ltd | 光学活性なフエニルセリン誘導体の製造方法 |
| US5827871A (en) | 1991-06-26 | 1998-10-27 | Smithkline Beecham Plc | Medicaments 1,2,3,4-tetrahydrocarbazoles and 5-HT1 agonist use thereof |
| GB9113802D0 (en) | 1991-06-26 | 1991-08-14 | Smithkline Beecham Plc | Medicaments |
| US5616603A (en) | 1995-05-26 | 1997-04-01 | Smithkline Beecham Plc | Enantiomers of carbazole derivatives as 5-HT1 -like agonists |
| GB9226530D0 (en) * | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
| IL110255A (en) * | 1993-07-16 | 1998-12-06 | Merck & Co Inc | Creation and resolution of 2 tert-butylcarboxamidopiprazine |
| JPH07229341A (ja) * | 1994-02-15 | 1995-08-29 | Takero Mori | 観音開き扉用ロック |
| US5618948A (en) | 1995-05-26 | 1997-04-08 | Smithkline Beecham P.L.C. | Process for preparing an enantiomer of a carbazole derivative |
| US5917054A (en) | 1995-07-18 | 1999-06-29 | Smithkline Beecham P.L.C. | Process for preparing enantiomers of carbazole derivatives as 5-HT1 -like agonists |
-
1998
- 1998-04-16 GB GBGB9808069.0A patent/GB9808069D0/en not_active Ceased
-
1999
- 1999-04-16 MY MYPI99001476A patent/MY126530A/en unknown
- 1999-04-16 MX MXPA00010127A patent/MXPA00010127A/es active IP Right Grant
- 1999-04-16 ES ES99915957.7T patent/ES2541432T3/es not_active Expired - Lifetime
- 1999-04-16 HU HU0101445A patent/HU230559B1/hu unknown
- 1999-04-16 PL PL343528A patent/PL210864B1/pl unknown
- 1999-04-16 AR ARP990101781A patent/AR015771A1/es active IP Right Grant
- 1999-04-16 JP JP2000544643A patent/JP4756740B2/ja not_active Expired - Lifetime
- 1999-04-16 CA CA2328345A patent/CA2328345C/en not_active Expired - Lifetime
- 1999-04-16 IL IL13901799A patent/IL139017A/xx not_active IP Right Cessation
- 1999-04-16 YU YU62800A patent/YU62800A/sh unknown
- 1999-04-16 WO PCT/GB1999/001167 patent/WO1999054302A1/en active IP Right Grant
- 1999-04-16 EA EA200001080A patent/EA004586B1/ru not_active IP Right Cessation
- 1999-04-16 TR TR2001/00142T patent/TR200100142T2/xx unknown
- 1999-04-16 KR KR1020007011362A patent/KR100612183B1/ko active Protection Beyond IP Right Term
- 1999-04-16 EE EEP200000597A patent/EE05156B1/xx unknown
- 1999-04-16 CZ CZ20003823A patent/CZ297303B6/cs not_active IP Right Cessation
- 1999-04-16 ID IDW20002365A patent/ID26783A/id unknown
- 1999-04-16 UA UA2000116417A patent/UA70943C2/uk unknown
- 1999-04-16 SI SI9931077T patent/SI1070051T1/sl unknown
- 1999-04-16 AU AU34370/99A patent/AU3437099A/en not_active Abandoned
- 1999-04-16 SK SK1518-2000A patent/SK286425B6/sk not_active IP Right Cessation
- 1999-04-16 PT PT99915957T patent/PT1070051E/pt unknown
- 1999-04-16 CN CNB998072516A patent/CN1200931C/zh not_active Expired - Lifetime
- 1999-04-16 BR BR9909627-7A patent/BR9909627A/pt not_active Application Discontinuation
- 1999-04-16 DK DK99915957.7T patent/DK1070051T3/en active
- 1999-04-16 EP EP99915957.7A patent/EP1070051B1/en not_active Expired - Lifetime
- 1999-05-03 TW TW088107131A patent/TWI255812B/zh active
-
2000
- 2000-10-13 US US09/689,661 patent/US6359146B1/en not_active Expired - Lifetime
- 2000-10-13 NO NO20005158A patent/NO317883B1/no not_active IP Right Cessation
- 2000-10-16 HR HRP20000683AA patent/HRP20000683B1/hr not_active IP Right Cessation
- 2000-11-03 ZA ZA200006303A patent/ZA200006303B/en unknown
-
2001
- 2001-11-20 HK HK01108166A patent/HK1037615A1/xx unknown
-
2015
- 2015-06-23 CY CY20151100532T patent/CY1116418T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100937915B1 (ko) | 변형된 픽텟-스펭글러 반응 및 그것으로부터 제조된생성물 | |
| TW200808770A (en) | Novel processes for the preparation of DPP IV inhibitors | |
| JP2018008985A (ja) | （５−フルオロ−２−メチル−３−キノリン−２−イルメチル−インドール−１−イル）−酢酸エステルの製造のための方法 | |
| HU228204B1 (en) | New process for the preparation of 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine and use thereof for the synthesis of tianeptine | |
| EA002151B1 (ru) | Способ получения замещенного пергидроизоиндола | |
| ZA200006303B (en) | Process for the production or R-(+)-6-carboxamido-3-N-methylamino-1,2,3,4-tetrahydrocarbazole. | |
| KR20040027404A (ko) | 글리시딜프탈이미드의 제조방법 | |
| WO2017094031A2 (en) | Novel process for preparation of apremilast | |
| CN110746334B (zh) | 一种制备3-(3-氯丙基)-4-氧代吡咯烷-1-羧酸酯的方法 | |
| US20030083506A1 (en) | Process for the preparation of an indole derivative | |
| JP2002512227A5 (pl) | ||
| CN110724098A (zh) | 一种5,7-二氯-1,2,3,4-四氢异喹啉-6-羧酸盐酸盐的合成方法 | |
| AU725210B2 (en) | Preparation of 1-butyl-4-piperidinylmethylamine | |
| Danieli et al. | An expeditious synthesis of dimethyl 1-benzyl-cis-piperidine-3, 5-dicarboxylate | |
| EP1097136B1 (en) | Process for the preparation of an indole derivative | |
| HU214581B (hu) | N2-(1S)-(1-/Etoxi-karbonil/-3-fenil-propil)-N6-(trifluor-acetil)-(L)-lizil-(L)-prolin-benzil-észter és eljárás előállítására | |
| CN116685582A (zh) | (s)-1-(1-丙烯酰吡咯烷-3-基)-3-((3,5-二甲氧苯基)乙炔基)-5-(甲基氨基)-1h-吡唑-4-甲酰胺的制备工艺 | |
| JP4520145B2 (ja) | ３−スピロ［シクロヘキサン−１，３’−［３ｈ］インドリン］−２’−オン誘導体の調製のための方法 | |
| CZ286483B6 (en) | Derivatives of 2-azabicyclo/2,2,1/heptane and process of their preparation | |
| CZ9903591A3 (cs) | Způsob přípravy hydrogenhalogenidů ethylesteru kyseliny 1-methyl-4-fenyl-4-piperidinkarboxylové a meziprodukty k jeho provádění | |
| TW200305418A (en) | Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams |